Nuclear Mechanisms Involved in Endocrine Resistance

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Endocrine therapy is a cornerstone for estrogen receptor α (ERα)-positive breast cancer.
• Endocrine resistance, a major clinical challenge, reduces treatment efficacy.
• Resistance mechanisms often involve pathway deregulation, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review and summarize current knowledge on nuclear mechanisms underlying endocrine resistance in ERα-positive breast cancer.
• To highlight emerging nuclear targets for overcoming endocrine resistance.
• To provide insights for improving patient outcomes in endocrine-resistant breast cancer.

Main Methods:

• Literature review of studies investigating endocrine resistance in breast cancer.
• Analysis of molecular mechanisms, focusing on nuclear pathways.
• Synthesis of findings related to PI3K/AKT/mTOR and CDK4/6 pathways.

Main Results:

• Endocrine resistance is frequently associated with dysregulation of key signaling pathways.
• Emerging evidence points to critical roles of nuclear mechanisms in mediating resistance.
• Inhibitors targeting PI3K/AKT/mTOR and CDK4/6 pathways show clinical utility.

Conclusions:

• Understanding nuclear mechanisms is crucial for developing strategies against endocrine resistance.
• Identification of novel druggable nuclear targets can enhance therapeutic options.
• Further research into these mechanisms promises to improve outcomes for breast cancer patients.